Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study.

Walker AJ, Grainge MJ, Card TR.

Br J Cancer. 2012 Oct 23;107(9):1602-7. doi: 10.1038/bjc.2012.427. Epub 2012 Sep 25.

2.

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.

Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ.

Am J Gastroenterol. 2011 Jul;106(7):1340-50. doi: 10.1038/ajg.2011.38. Epub 2011 Mar 15.

3.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

4.

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.

Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM.

Gut. 2011 Apr;60(4):491-8. doi: 10.1136/gut.2010.221143. Epub 2010 Nov 4.

5.

Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.

Li P, Wu H, Zhang H, Shi Y, Xu J, Ye Y, Xia D, Yang J, Cai J, Wu Y.

Gut. 2015 Sep;64(9):1419-25. doi: 10.1136/gutjnl-2014-308260. Epub 2014 Sep 19. Review.

PMID:
25239119
6.

Aspirin use and survival after diagnosis of colorectal cancer.

Chan AT, Ogino S, Fuchs CS.

JAMA. 2009 Aug 12;302(6):649-58. doi: 10.1001/jama.2009.1112.

7.

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.

Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA, Cetnarskyj R, Stark L, Porteous ME, Campbell H, Dunlop MG.

Gut. 2010 Dec;59(12):1670-9. doi: 10.1136/gut.2009.203000. Epub 2010 Sep 15. Review.

PMID:
20844293
8.

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.

García-Rodríguez LA, Huerta-Alvarez C.

Epidemiology. 2001 Jan;12(1):88-93.

PMID:
11138826
9.

Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

Hua X, Phipps AI, Burnett-Hartman AN, Adams SV, Hardikar S, Cohen SA, Kocarnik JM, Ahnen DJ, Lindor NM, Baron JA, Newcomb PA.

J Clin Oncol. 2017 Aug 20;35(24):2806-2813. doi: 10.1200/JCO.2017.72.3569. Epub 2017 Jun 15.

PMID:
28617623
10.

Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.

Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent JA, Neuhausen SL, Stram DO, Ursin G, Anton-Culver H.

Cancer. 2009 Dec 15;115(24):5662-71. doi: 10.1002/cncr.24705.

11.

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.

Grau MV, Sandler RS, McKeown-Eyssen G, Bresalier RS, Haile RW, Barry EL, Ahnen DJ, Gui J, Summers RW, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):267-76. doi: 10.1093/jnci/djn484. Epub 2009 Feb 10.

12.

Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.

Stürmer T, Buring JE, Lee IM, Kurth T, Gaziano JM, Glynn RJ.

Am J Med. 2006 Jun;119(6):494-502.

13.

Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.

McCowan C, Munro AJ, Donnan PT, Steele RJ.

Eur J Cancer. 2013 Mar;49(5):1049-57. doi: 10.1016/j.ejca.2012.10.024. Epub 2012 Nov 19.

PMID:
23182687
14.

Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.

Friis S, Riis AH, Erichsen R, Baron JA, Sørensen HT.

Ann Intern Med. 2015 Sep 1;163(5):347-55. doi: 10.7326/M15-0039.

PMID:
26302241
15.

The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.

Huang WK, Chiou MJ, Yu KH, Lin YC, Yang TS, Chen JS, Kuo CF, See LC.

Aliment Pharmacol Ther. 2013 Aug;38(4):432-9. doi: 10.1111/apt.12388. Epub 2013 Jun 25.

16.

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.

JAMA. 2005 Aug 24;294(8):914-23.

17.

Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.

Macfarlane TV, Murchie P, Watson MC.

Cancer Epidemiol. 2015 Dec;39(6):1015-22. doi: 10.1016/j.canep.2015.10.030. Epub 2015 Nov 18.

PMID:
26590503
18.

Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort.

Cardwell CR, Kunzmann AT, Cantwell MM, Hughes C, Baron JA, Powe DG, Murray LJ.

Gastroenterology. 2014 Mar;146(3):700-708.e2. doi: 10.1053/j.gastro.2013.11.005. Epub 2013 Nov 15.

PMID:
24239563
19.

Survival of glioma and colorectal cancer patients using tricyclic antidepressants post-diagnosis.

Walker AJ, Grainge M, Bates TE, Card TR.

Cancer Causes Control. 2012 Dec;23(12):1959-64. doi: 10.1007/s10552-012-0073-0. Epub 2012 Oct 12.

PMID:
23065071
20.

Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort.

Brasky TM, Potter JD, Kristal AR, Patterson RE, Peters U, Asgari MM, Thornquist MD, White E.

Cancer Causes Control. 2012 Mar;23(3):431-44. doi: 10.1007/s10552-011-9891-8. Epub 2012 Jan 3.

Supplemental Content

Support Center